Skip to main content
Springer Nature Link
Log in

Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients

  • Original Article
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

Abstract

The purpose of this study was to investigate the relationship between fasting serum leptin, adiponectin and resistin levels and bone mineral density (BMD) in osteoporosis patients and a non-osteoporosis control group. We studied 81 non-diabetic osteoporosis patients (92 % female, 8 % male; mean age 54.5 ± 15.5 years and body mass index [BMI] 28.2 ± 4.6) and 120 non-diabetic individuals with normal BMD as controls (86 % female, 14 % male; mean age 39.7 ± 10.4 years and BMI 28.8 ± 4.4). BMD was studied by dual-energy X-ray absorptiometry from the lumbar spine (L1–L4) and femoral neck and fasting blood samples were taken for biochemical measurement of fasting blood glucose, leptin, adiponectin and resistin. Fasting levels of plasma adiponectin had a significant negative correlation with BMD of the femoral neck and lumbar spine in the osteoporosis group (r = −0.478, P = 0.003, r = −0.513, P = 0.023) but not in the non-osteoporosis group (r = −0.158, P = 0.057, r = −0.23, P = 0.465). Fasting plasma levels of resistin were significantly correlated only with femur BMD in the osteoporosis group, and not significantly correlated with lumbar spine BMD (r = −0.244, P = 0.048 vs r = 0.276, P = 0.56). Leptin did not have a significant correlation with BMD in either the osteoporosis or non-osteoporosis groups (P > 0.05). Adiponectin had a significant negative correlation with BMD of the lumbar spine and femoral neck. The correlation between leptin and resistin are not inconclusive.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lim S, Joung H, Shin CS, Lee HK, Kim KS, Shin EK, Kim HY, Lim MK, Cho SI (2004) Body composition changes with age have gender-specific impacts on bone mineral density. Bone 35:792–798

    Article  PubMed  Google Scholar 

  2. Felson DT, Zhang Y, Hannan MT, Anderson J (1993) Effects of weight and body mass index on bone mineral density in men and women. J Bone Miner Res 8:567–573

    Article  CAS  PubMed  Google Scholar 

  3. Glauber HS, Vollmer WM, Nevitt MC, Ensrud KE, Orwoll ES (1995) Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab 80:1118–1123

    CAS  PubMed  Google Scholar 

  4. Lenchik L, Register TC, Lohman K, Hsu F-C, Nicklas BJ, Freedman BI, Langefeld CD, Carr JJ, Bowden DW (2003) Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone 33:646–651

    Article  CAS  PubMed  Google Scholar 

  5. won Muhlen D, Safii S, Jassal SK, Svartberg J, Barrett-Connor E (2007) Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int 18:1337–1344

    Article  Google Scholar 

  6. Maeda K, Okubo K, Shimomura I, Mizuno K, Matsuzawa Y, Matsubara K (1997) Analysis of an expression profile of genes in the human adipose tissue. Gene 190:227–235

    Article  CAS  PubMed  Google Scholar 

  7. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura Nakamura T et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83

    Article  CAS  PubMed  Google Scholar 

  8. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L (2001) Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001) The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947–953

    Article  CAS  PubMed  Google Scholar 

  10. Kanazawa I, Yamaguchi T, Yano S, Yamauchi M, Yamamoto M, Sugimoto T (2007) Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol 8:51–62

    Article  PubMed Central  PubMed  Google Scholar 

  11. Berner HS, Lyngstadaas SP, Spahr A, Monjo M, Thommesen L, Drevon CA, Syversen U, Reseland JE (2004) Adiponectin and its receptors are expressed in bone-forming cells. Bone 35:842–849

    Article  CAS  PubMed  Google Scholar 

  12. Williams GA, Wang Y, Callon KE, Watson M, Lam JB, Lin JM, Janice BB, Costa JL, Orpe A, Broom N, Naot D, Reid IR, Cornish J (2009) In vitro and in vivo effects of adiponectin on bone. Endocrinology 150:3603–3610

    Article  CAS  PubMed  Google Scholar 

  13. Brennan AM, Mantzoros CS (2006) Drug insight: the role of leptin in human physiology and pathophysiology-emerging clinica applications. Nat Rev Endocrinol 2:318–327

    CAS  Google Scholar 

  14. Thomas T, Burguera B, Melton LJ, Atkinson E, Riggs BL, Khosla S (2004) Relationship of serum leptin levels with body composition, sex steroid, and insulin levels in women and men. Metabolism 9:1278–1284

    Google Scholar 

  15. Burguera B, Hofbau L, Thomas L, Gori F, Lamsam J et al (2001) Leptin reduces ovariectomy-induced bone loss. Endocrinology 142:3546–3553

    Article  CAS  PubMed  Google Scholar 

  16. Ducy P, Amling M, Takeda S, Priemel M, Schilling AF et al (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207

    Article  CAS  PubMed  Google Scholar 

  17. Jürimäe J, Jürimäe T, Leppik A, Kums T (2008) The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab 26:618–623

    Article  PubMed  Google Scholar 

  18. OdabaI E, Ozata M, Turan M, Bingo N, Yonem A, Cakir B, Kutlu M, Ozdemir IC (2000) Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 142:170–173

    Article  Google Scholar 

  19. Gonnelli S, Caffarelli C, Del Santo K, Cadirni A, Guerriero C, Lucani B, Franci B, Nuti R (2008) The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 83:55–60

    Article  CAS  PubMed  Google Scholar 

  20. Ozkurt B, Ozkurt ZN, Altay M, Aktekin CN, Caðlayan O, Tabak Y (2009) The relationship between serum adiponectin level and anthropometry bone mass osteoporotic fracture skin postmeno-pausal women. Eklem Hastalik Cerrahisi 20:78–84

    PubMed  Google Scholar 

  21. Canhao H, Fonseca JE, Caetano-Lopes J, Saldanha C, Queiroz MV (2008) Assessment of laboratory measurements and -308 TNF gene promoter polymorphisms in normal bone mineral density. Clin Rheumatol 27:301–307

    Article  PubMed  Google Scholar 

  22. Kontogianni MD, Dafni UG, Routsias G, Skopouli FN (2004) Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 19:546–551

    Article  CAS  PubMed  Google Scholar 

  23. Pang XD, Xian H, Zhao Q, Wu XP, Sun ZQ, Liao EY (2008) Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta 387:31–35

    Article  Google Scholar 

  24. Jürimäe J, Jürimäe T (2007) Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos Int 18:1253–1259

    Article  PubMed  Google Scholar 

  25. Jurima J, Rembel K, Jurimae T, Rehand M (2005) Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res 37:297–302

    Article  Google Scholar 

  26. Ealey KN, Kaludjerovic J, Archer MC, Ward WE (2008) Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood) 233:1546–1553

    Article  CAS  Google Scholar 

  27. Richards JB, Valdes AM, Burling K, Perks UC, Spector TD (2007) Serum adiponectin and bone mineral density in women. ICEM 92:1517–1523

    CAS  Google Scholar 

  28. Sato M, Takeda N, Sarui H, Takami R, Takami K, Hayashi M et al (2001) Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. JCEM 86:5273–5276

    CAS  PubMed  Google Scholar 

  29. Zhong N, Wu XP, Xu ZR, Wang AH, Luo XH, Cao XZ, Xie H, Shan PF, Liao EY (2005) Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Clin Chim Acta 351:161–168

    Article  CAS  PubMed  Google Scholar 

  30. Parm AL, Jürimäe J, Saar M, Pärna K, Tillmann V, Maasalu K, Neissaar I, Jürimäe T (2011) Plasma adipocytokine and ghrelin levels in relation to bone mineral density in prepubertal rhythmic gymnasts. J Bone Miner Metab 9:717–724

    Article  Google Scholar 

  31. Tamura T, Yoneda M, Yamane K, Nakanishi S, Nakashima R, Okubo M, Kohno N (2007) Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism 56:623–628

    Article  CAS  PubMed  Google Scholar 

  32. Oshima K, Nampei AM, Iwaki M, Fukuhara A, Hashimoto J, Yoshikawa H, Shimomura I (2005) Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 331:520–526

    Article  CAS  PubMed  Google Scholar 

  33. Luo XH, Guo LJ, Xie H, Yuan LQ, Wu XP, Zhou HD, Liao EY (2006) Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res 21:1648–1656

    Article  CAS  PubMed  Google Scholar 

  34. Kajimura D, Lee HW, Riley KJ, Arteaga-Solis E, Ferron M, Zhou B, Clarke CJ, Hannun YA, Depinho RA, Guo EX, Mann JJ, Karsenty G (2013) Adiponectin regulates bone mass via opposite central and peripheral mechanism through FoxO1. Cell Metab 17:901–915

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  35. Shinoda Y, Yamaguchi M, Ogata N (2006) Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 99:196–208

    Article  CAS  PubMed  Google Scholar 

  36. Atalay A, Elic H, Kayadibi N, Nurettin A (2012) Diagnostic utility of osteocalcin, under carboxylated osteocalcin and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med 32:23–30

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Ochoa S, Arantazu F, Diego R, Rebeca M, Raya M, Manuel M (2012) Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with reloxifene or alendronate. Menopause 19:172–177

    Article  Google Scholar 

  38. Biver E, Salliot C, Combescure C, Gossec L, Hardouin P, Legroux-Gerot I, Cortet B (2011) Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab 21:56–61

    Google Scholar 

  39. Chanprasertyothin S, Piaseu N, Chailurkit L, Rajatanavin R, Ongphiphadhanakul B (2005) Association of circulating leptin with bone mineral density in males and females. J Med Assoc Thai 88:655–659

    PubMed  Google Scholar 

  40. Martini G, Valenti R, Giovani S, Franci B, Campagna S, Nuti R (2001) Influence of insulin- like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone 28:113–117

    Article  CAS  PubMed  Google Scholar 

  41. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, Yamauchi T et al (2002) Genetic variation in the gene encoding adiponectin in associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51:536–540

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by Shahid Sadoughi University of Medical Sciences. We greatly acknowledge Research Deputy of Shahid Sadoughi University of Medical Sciences for supporting the present project.

Conflict of interest

The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the research reported.

Author information

Authors and Affiliations

  1. Department of Biochemistry and Molecular Biology, Faculty of Medicine, Shahid Saduoghi University of Medical Science, Yazd, Iran

    J. Mohiti-Ardekani

  2. Department of Rheumatology, Faculty of Medicine, Shahid Saduoghi University of Medical Science, Yazd, Iran

    H. Soleymani-Salehabadi & M. B. Owlia

  3. Faculty of Medicine, Shahid Saduoghi University of Medical Science, Yazd, Iran

    A. Mohiti

Authors
  1. J. Mohiti-Ardekani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Soleymani-Salehabadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. B. Owlia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Mohiti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Mohiti-Ardekani.

About this article

Cite this article

Mohiti-Ardekani, J., Soleymani-Salehabadi, H., Owlia, M.B. et al. Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients. J Bone Miner Metab 32, 400–404 (2014). https://doi.org/10.1007/s00774-013-0511-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-013-0511-4

Keywords

Search

Navigation